Molecular/functional image-guided intensity modulated radiation therapy

Image-Guided IMRT

Volumn , Issue , 2006, Pages 187-198

  Xing, Lei ^a   Yang, Yong ^a   Spielman, Daniel M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33746823307     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/3-540-30356-1_15     Document Type: Chapter

References (55)

1. Webb S (2001) Intensity-modulated radiation therapy. Institute of Physics Publishing, Bristol, pp xv, 633
2. IMRT Collaborative Working Group (2001) Intensity modulated radiotherapy: current status and issues of interest. Int J Radiat Oncol Biol Phys 51:880-914
3. AAPM IMRT Sub-committee (2003) Guidance document on delivery, treatment planning, and clinical implementation of IMRT: Report of the IMRT subcommittee of the AAPM radiation therapy committee. Med Phys 30:2089-2115
4. Carol M, Grant WH III, Pavord D et al. (1996) Initial clinical experience with the Peacock intensity modulation of a 3D conformal radiation therapy system. Stereotactic Functional Neurosurg 66:30-34
5. Ling CC, Burman C, Chui CS et al. (1996) Conformal radiation treatment of prostate cancer using inverselyplanned intensity-modulated photon beams produced with dynamic multileaf collimation. Int J Radiat Oncol Biol Phys 35:721-730
6. Woo SY, Grant WH III, Bellezza D et al. (1996) A comparison of intensity-modulated conformal therapy with a conventional external beam stereotactic radiosurgery system for the treatment of single and multiple intracranial lesions. Int J Radiat Oncol Biol Phys 35:593-597
7. Le QT, Xing L, Boyer AL (1999) Head and Neck IMRT - The StanfordExperience, International Symposium:3DConformal Radiation Therapy and Intensity Modulated Radiation Therapy in New Millenium, vol 42. Medical Physics Publishing, Houston
8. Hancock S,LuxtonG,ChenY,Xing L,BoyerAL(2000) Intensity modulated radiotherapy for localized or regional treatment of prostate cancer: clinical implementation and improvement in acute tolerance, Annual meeting of ASTRO, Boston, MA
9. Teh BS, Mai WY, Uhl BM et al. (2001) Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis. Int J Radiat Oncol Biol Phys 49:705-712
10. Huang E, Teh BS, StrotherDRet al. (2002) Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity. Int J Radiat Oncol Biol Phys 52:599-605
11. Mundt AJ, Lujan AE, Rotmensch J et al. (2002) Intensitymodulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 52:1330-1337
12. Mundt AJ, Roeske JC, Lujan AE et al. (2001) Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies. Gynecol Oncol 82:456-463
13. Chao KS, Deasy JO,Markman J et al. (2001)Aprospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 49:907-916
14. Lee N, Xia P, Quivey JM et al. (2002) Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phy 53:12-22
15. Eisbruch A (2002) Intensity-modulated radiotherapy of headand- neck cancer: encouraging early results. Int J Radiat Oncol Biol Phys 53:1-3
16. Ling CC, Humm J, Larson S et al. (2000) Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 47:551-560
17. Goitein M, Niemierko A (1997) Intensity modulated therapy and inhomogeneous dose to the tumor: a note of caution. Comment in: Int J Radiat Oncol Biol Phys 38(5):1138-1139; (1996).
18. Int J Radiat Oncol Biol Phys 36:519-522
19. Macklis R, Weinhous M, Harnisch G (2000) Intensitymodulated radiotherapy: rethinking basic treatment planning paradigms. Int J Radiat Oncol Biol Phys 48:317-318
20. Rosenman J (2001) Incorporating functional imaging information into radiation treatment. Semin Radiat Oncol 11:83-92
21. Xing L, Cotrutz C, Hunjan S, Boyer AL, Adalsteinsson E, SpielmanDM( 2002) Inverse planning for functional image-guided IMRT. Phys Med Biol 47:3567-3578
22. Alber M, Paulsen F, Eschman SM, Machulla HJ (2003) On biologically conformal boost dose optimization. Phys Med Biol 48:N31-N35
23. Contag CH, Ross BD (2002) It's not just about anatomy: in vivo bioluminescence imaging as an eyepiece into biology. J Magn Reson Imag 16:378-387
24. Seltzer M, Schiepers C, Silverman DH et al. (2001) Recent advances in imaging endogenous or transferred gene expression utilizing radionuclide technologies in living subjects: applications to breast cancer. J Nucl Med 42:586-590
25. Cheery SR(2003) In vivo molecular and genomic imaging: new challenges for imaging physics. Phys Med Biol 49:R13-R48
26. Kurhanewicz J, Vigneron DB, Hricak H et al. (1996) Threedimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7 cm3) spatial resolution prostate carcinoma: MR imaging findings after cryosurgery. Radiology 198:795-805
27. Zaider M, Zelefsky MJ, Lee EK et al. (2000) Treatment planning for prostate implants using magnetic-resonance spectroscopy imaging. Int J Radiat Oncol Biol Phys 47:1085-1096
28. DiBiase SJ, Hosseinzadeh K, Gullapalli RP et al. (2002) Magnetic resonance spectroscopic imaging-guided brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 52:429-438
29. Kim D, Mayer D, Xing L, Daniel D, Spielman D (2005) In vivo detection of citrate for prostate cancer at 3 Tesla. Magn Reson Med (in press)
30. Lian J, Xing L, Hunjan S et al. (2004) Mapping of the prostate in endorectal coil-based MRI|MRSI and CT: a deformable registration and validation study. Med Phys 31:3087-3094
31. Zaider M, Minerbo GN (2000) Tumour control probability: a formulation applicable to any temporal protocol of dose delivery. Phys Med Biol 45:279-293
32. Lian J, Hunjan S, Dumoulin C, Levin J, Watkins R, Rohling K, Giaquinto R, KimD, Lo A, Spielman D, Daniel B, Xing L (2003) Integrating deformable MRI|MRSI and CT image registration into the prostate IMRT treatment planning. Int J Radiat Oncol Biol Phys 57:S207
33. Bookstein FL (1989) Thin plate splines and the decomposition of deformations. IEEE Trans Pattern Anal Mach Intell 11:567-585
34. Wu X, Yu C, DiBiase SJ, Gullapallib R (2003) The application of deformable image registration for MRS in prostate treatment planning. Int J Radiat Oncol Biol Phys 57:S208
35. Mutic S, Dempsey JF, Markman J, Chao KS, Purdy JA (2001) Multimodality image registration quality assurance for conformal three-dimensional treatment planning. Med Dosim 26:79-82
36. Hunjan S, Adalsteinsson E, Kim DH et al. (2003) Quality assurance of magnetic resonance spectroscopic imagingderived metabolic data. Int J Radiat Oncol Biol Phys 57: 1159-1173
37. Hunjan S, Spielman DM, Adalsteinsson E, Boyer AL, Xing L (2002) Phantom for quality assurance testing of MRSI data incorporated into radiation treatment planning. In: Proceeding of Annual Meeting of International Associate of Magnetic Resonance in Medicine, Honolulu, Hawaii
38. Xing L,Cotrutz C, Hunjan S, BoyerAL, Adalsteinsson E, Spielman D (2002) Inverse planning for functional image-guided IMRT. Oral Presentation in 2002 Annual Meeting of ASTRO, New Orleans, LA
39. Niemierko A (1997) Reporting and analyzing dose distributions: a concept of equivalent uniform dose. Med Phys 24:103-110
40. Lyman JT,Wolbarst AB (1987) Optimization of radiation therapy, III: A method of assessing complication probabilities from dose-volume histograms. Int J Radiat Oncol Biol Phys 13:103-109
41. Xing L, Li JG, Donaldson S, Le QT, Boyer AL (1999) Optimization of importance factors in inverse planning. Phys Med Biol 44:2525-2536
42. Shou Z, Xing L (2003) Improve IMRT dose distribution by using spatially non-uniform dose importance factors. Proceeding of the 14th ICCR. Seoul, Korea
43. Cotrutz C, Xing L (2002) Using voxel-dependent importance factors for interactive DVH-based dose optimization. Phys Med Biol 47:1659-1669
44. Cotrutz C, Xing L (2003) IMRT dose shaping using regionally variable penalty scheme. Med Phys 30:544-551
45. Wu C, Olivera GH, Jeraj R, Keller H, Mackie TR (2003) Treatment plan modification using voxel-based weighting factors|dose prescription. Phys Med Biol 48:2479-2491
46. Yang Y, Xing L (2005) Towards biologically conformal radiation therapy (BCRT): selective IMRT dose escalation under the guidance of spatial biology distribution. Med Phys (in press)
47. Crooks S, Xing L (2002) Constraint least square method for inverse treatment planning. Int J Radiat Oncol Biol Phys 54:1217-1224
48. Lu Y, Spelbring DR, Chen GT (1997) Functional dose-volume histograms for functionally heterogeneous normal organs. Phys Med Biol 42:345-356
49. Marks LB, Sherouse GW, Munley MT, Bentel GC, Spencer DP, Scarfone C (1999) Incorporation of functional status into dose-volume analysis quantitative pulmonary single photon emission computed tomography for radiotherapy applications. Med Phys 26:196-199
50. Alber M, Nusslin F (2002) Tools for the analysis of dose optimization: I. Effect-volume histogram. Phys Med Biol 47:2451-2458
51. MartelMK, TenHaken RK,HazukaMB, TurrisiAT, Fraass BA, Lichter AS (1994) Dose-volume histogram and 3D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Biol Phys 28:575-581
52. Martel MK, Ten Haken RK, Hazuka MB et al. (1999) Estimation of tumor control probability model parameters from 3D dose distributions of non-small cell lung cancer patients. Lung Cancer 24:31-37
53. Webb S, Nahum AE (1993) A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Phy Med Biol 38:653-666
54. Niemierko A, GoiteinM(1993) Implementation of amodel for estimating tumor control probability for an inhomogeneously irradiated tumor. Radiother Oncol 29:140-147
55. Popple RA, Ove R, Shen S (2002) Tumor control probability for selective boosting of hypoxic subvolumes, including the effect of reoxygenation. Int J Radiat Oncol Biol Phys 54:921-927